SCHEMBL23905365

SCHEMBL23905365

CC/N=C(/c1ccc(C(F)(F)F)cc1)C(C)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
SRD5A2 P31213 2/20 0.40
GRIN2B Q13224 3/20 0.39
PDE2A O00408 3/20 0.39
GSK3B P49841 2/20 0.39
PTPN1 P18031 2/20 0.39
LMNA P02545 2/20 0.37
SLC6A4 P31645 1/20 0.37
CYP3A4 P08684 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
CYP2C19 P33261 1/20 0.36
NOS2 P35228 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905645 0.81 ALDH1A1 (0.39) CES2CES1PTPN1LMNAALDH1A1
SCHEMBL20696663 0.73 CES2 (0.40) CES2CES1SRD5A2GRIN2BPDE2A
SCHEMBL11442428 0.72 CES2 (0.45) CES2CES1SRD5A2GRIN2BPDE2A
SCHEMBL8553654 0.69 CES2 (0.65) CES2CES1SRD5A2GSK3BPTPN1
SCHEMBL8402410 0.69 GRIN2B (0.36) CES2CES1GRIN2BPDE2ALMNA
SCHEMBL13731810 0.65 ALDH1A1 (0.61) CES2CES1SRD5A2GSK3BPTPN1
SCHEMBL13731809 0.65 ALDH1A1 (0.61) CES2CES1SRD5A2GSK3BPTPN1
SCHEMBL16563626 0.65 GAA (0.46) CES2CES1SRD5A2GRIN2BPDE2A
SCHEMBL15761193 0.65 GAA (0.46) CES2CES1SRD5A2GRIN2BPDE2A
SCHEMBL17133996 0.65 GAA (0.46) CES2CES1SRD5A2GRIN2BPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed